{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2015-P-2820\" sorted by posted_date descending", "rows": [["FDA-2015-P-2820-0078", "FDA", "FDA-2015-P-2820", "Second interim response from FDA OP to Center for Responsible Science", "Other", "Letter(s)", "2019-03-25T04:00:00Z", 2019, 3, "2019-03-25T04:00:00Z", null, "2019-03-25T17:05:28Z", null, 0, 0, "0900006483b28087"], ["FDA-2015-P-2820-0077", "FDA", "FDA-2015-P-2820", "Interim Response Letter from FDA  to  Alston and Bird (the Center for Responsible Science)", "Other", "Response(s)", "2018-12-21T05:00:00Z", 2018, 12, "2018-12-21T05:00:00Z", null, "2019-01-30T19:53:10Z", null, 0, 0, "09000064839bfff8"], ["FDA-2015-P-2820-0076", "FDA", "FDA-2015-P-2820", "Amendment (fifth) from Center for Responsible Science (CRS)", "Other", "Amendment", "2018-03-13T04:00:00Z", 2018, 3, "2018-03-13T04:00:00Z", null, "2018-03-13T14:54:23Z", null, 0, 0, "09000064830072a5"], ["FDA-2015-P-2820-0075", "FDA", "FDA-2015-P-2820", "Amendment (Fourth)  from Center for Responsible Science (CRS)", "Other", "Amendment", "2017-10-05T04:00:00Z", 2017, 10, "2017-10-05T04:00:00Z", null, "2017-10-05T19:00:46Z", null, 0, 0, "0900006482b8c81c"], ["FDA-2015-P-2820-0074", "FDA", "FDA-2015-P-2820", "Amendment (third)  from Center for Responsible Science (CRS)", "Other", "Amendment", "2017-07-10T04:00:00Z", 2017, 7, "2017-07-10T04:00:00Z", null, "2017-07-11T18:45:09Z", null, 0, 0, "09000064828d1db1"], ["FDA-2015-P-2820-0073", "FDA", "FDA-2015-P-2820", "Declaration of Michael Vokhgelt", "Other", "Declaration(s)", "2017-05-05T04:00:00Z", 2017, 5, "2017-05-05T04:00:00Z", null, "2017-05-05T13:48:38Z", null, 0, 0, "09000064825921af"], ["FDA-2015-P-2820-0072", "FDA", "FDA-2015-P-2820", "Amendment from Center for Responsible Science (CRS)", "Other", "Amendment", "2017-05-04T04:00:00Z", 2017, 5, "2017-05-04T04:00:00Z", null, "2017-05-04T18:57:34Z", null, 0, 0, "090000648256fe13"], ["FDA-2015-P-2820-0070", "FDA", "FDA-2015-P-2820", "Exhibit 21 Lougheed, K. Hepatitis C drug trial halted after patient death August 24, 2012 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T16:24:31Z", null, 0, 0, "0900006481ecf1a7"], ["FDA-2015-P-2820-0066", "FDA", "FDA-2015-P-2820", "Exhibit 13 Brennan EMA Will Assess ANSM Review of Botched Clinical Trial in France, January 19, 2016 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T15:03:55Z", null, 0, 0, "0900006481ecf19f"], ["FDA-2015-P-2820-0067", "FDA", "FDA-2015-P-2820", "Exhibit 14 Attarwala, H. TGN1412; From Discovery to Disaster re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T15:15:59Z", null, 0, 0, "0900006481ecf1a0"], ["FDA-2015-P-2820-0071", "FDA", "FDA-2015-P-2820", "Exhibit 22 O'Riordan, M. After Patient's Death, Study Shows HCV Drug Cardiotoxic in 14 of 34 Treated Patients Source: www.medscape.com/viewarticle/832251_print September 24, 2014 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T16:31:17Z", null, 0, 0, "0900006481ed3d8d"], ["FDA-2015-P-2820-0064", "FDA", "FDA-2015-P-2820", "Exhibit 11 The Pharmaletter, ANSM continues investigations into Bial clinical trial death, March 10, 2016 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T14:51:57Z", null, 0, 0, "0900006481ecf19d"], ["FDA-2015-P-2820-0065", "FDA", "FDA-2015-P-2820", "Exhibit 12 Minutes of the Temporary Specialist Scientific Committee (TSSC) meeting on \"FAAH (Fatty Add Amide Hydrolase) Inhibitors\" of 15 February 2016. re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T14:58:22Z", null, 0, 0, "0900006481ecf19e"], ["FDA-2015-P-2820-0069", "FDA", "FDA-2015-P-2820", "Exhibit 20 Lerman, R. FDA halts trial of cancer drug by Seattle's CTI BioPharma after patients die, Source http://www.seattletimes.com/business/fda-halts-cti-biopharma-drug-trial-for-detrimental-effect-on-survival/ February 10, 2016 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T16:08:23Z", null, 0, 0, "0900006481ecf1a6"], ["FDA-2015-P-2820-0062", "FDA", "FDA-2015-P-2820", "Exhibit 8 Business Insider, Feb 5, 2016 Authorities are rapping up their investigation of a deadly drug trial that left one dead and several others in hospital re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T14:31:05Z", null, 0, 0, "0900006481ecf19a"], ["FDA-2015-P-2820-0063", "FDA", "FDA-2015-P-2820", "Exhibit 9 The Guardian Man who died in French drug trial had 'unprecedented' reaction, say experts. March 2016 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T14:39:36Z", null, 0, 0, "0900006481ecf19b"], ["FDA-2015-P-2820-0068", "FDA", "FDA-2015-P-2820", "Exhibit 16 Scientific Bloggging Science 2.0 Blood Test Predicts Cytokine Storm Drug Reaction In Humans March 9, 2015 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-21T04:00:00Z", 2016, 3, null, null, "2016-03-21T15:29:46Z", null, 0, 0, "0900006481ecf1a2"], ["FDA-2015-P-2820-0059", "FDA", "FDA-2015-P-2820", "Exhibit 1 Advancing Regulatory Science at FDA August 2011 re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:55:18Z", null, 0, 0, "0900006481ecf142"], ["FDA-2015-P-2820-0058", "FDA", "FDA-2015-P-2820", "Amendment from Center for Responsible Science (CRS)", "Other", "Amendment", "2016-03-18T04:00:00Z", 2016, 3, "2016-03-18T04:00:00Z", null, "2016-03-18T16:50:12Z", null, 0, 0, "0900006481eceacd"], ["FDA-2015-P-2820-0061", "FDA", "FDA-2015-P-2820", "Exhibit 7 Online News Articles from Different Organizations re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:14:44Z", null, 0, 0, "0900006481ecf199"], ["FDA-2015-P-2820-0060", "FDA", "FDA-2015-P-2820", "Exhibit 2 Baker et al How Regulatory Updates Allowing for\nMore Modern Test Methods, Pragmatic Validation of Preclinical Test Methods, and FDA Guidances Will Lead to Advancement of More Predictive Preclinical Testing Tools, Efficiency, and Safer and More Effective Drugs FDLI Food and Drug Policy Forum re: Amendment from Center for Responsible Science", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:59:37Z", null, 0, 0, "0900006481ecf143"], ["FDA-2015-P-2820-0057", "FDA", "FDA-2015-P-2820", "Interim Response from FDA CDRH to Alston & Bird, LLP", "Other", "Letter(s)", "2016-03-14T04:00:00Z", 2016, 3, "2016-03-14T04:00:00Z", null, "2016-03-14T13:56:23Z", null, 0, 0, "0900006481ebff6f"], ["FDA-2015-P-2820-0056", "FDA", "FDA-2015-P-2820", "Status Inquiry re Requests that the FDA modify existing regulations in Title 21 of the Code of Federal Regulations (CFR) that govern requirements for investigational new drug (IND) applications, investigational device exemptions (IDE), and new drug applications (NDAs).", "Supporting & Related Material", "Background Material", "2016-03-09T05:00:00Z", 2016, 3, null, null, "2016-03-09T17:21:15Z", null, 0, 0, "0900006481eb5c8b"], ["FDA-2015-P-2820-0005", "FDA", "FDA-2015-P-2820", "Exhibit B Regulation Updates re Citizen Petition from the Center for Responsible Science", "Supporting & Related Material", "Background Material", "2015-08-04T04:00:00Z", 2015, 8, null, null, "2015-08-04T15:30:30Z", null, 0, 0, "0900006481bbb056"], ["FDA-2015-P-2820-0001", "FDA", "FDA-2015-P-2820", "Citizen Petition from Alston and Bird (the Center for Responsible Science)", "Other", "Citizen Petition", "2015-08-04T04:00:00Z", 2015, 8, "2015-08-04T04:00:00Z", null, "2024-11-12T05:37:06Z", null, 1, 0, "0900006481bbadf8"], ["FDA-2015-P-2820-0003", "FDA", "FDA-2015-P-2820", "Acknowledgement Letter from FDA DDM to Alston and Bird LLP", "Other", "Acknowledgement Letter/Receipt", "2015-08-04T04:00:00Z", 2015, 8, "2015-08-04T04:00:00Z", null, "2015-08-04T15:27:48Z", null, 0, 0, "0900006481bbb052"], ["FDA-2015-P-2820-0004", "FDA", "FDA-2015-P-2820", "Exhibit A List of Petitioners re Citizen Petition from the Center for Responsible Science", "Supporting & Related Material", "Background Material", "2015-08-04T04:00:00Z", 2015, 8, null, null, "2015-08-04T15:29:28Z", null, 0, 0, "0900006481bbb055"], ["FDA-2015-P-2820-0002", "FDA", "FDA-2015-P-2820", "Letter from Alston and Bird LLP to FDA DDM", "Other", "Letter(s)", "2015-08-04T04:00:00Z", 2015, 8, "2015-08-04T04:00:00Z", null, "2015-08-04T15:26:27Z", null, 0, 0, "0900006481bbadfb"]], "truncated": false, "filtered_table_rows_count": 28, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2015-P-2820"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820", "results": [{"value": "FDA", "label": "FDA", "count": 28, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2015-P-2820", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820", "results": [{"value": 2016, "label": 2016, "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&posted_year=2016", "selected": false}, {"value": 2015, "label": 2015, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&posted_year=2015", "selected": false}, {"value": 2017, "label": 2017, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&posted_year=2017", "selected": false}, {"value": 2018, "label": 2018, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&posted_year=2018", "selected": false}, {"value": 2019, "label": 2019, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&posted_year=2019", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-P-2820&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1219.5916038472205, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}